免疫血液學市場規模、佔有率、成長分析、按產品、按最終用途、按地區 - 行業預測，2024-2031 年

Immunohematology Market Size, Share, Growth Analysis, By Product (Immunohematology analyzer, Immunohematology reagent), By End Use (Hospitals, Blood banks), By Region - Industry Forecast 2024-2031

出版日期: 2024年10月01日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年，免疫血液學的全球市場規模為18.3億美元，從2023年的19.2億美元成長到2031年的27.6億美元，預計在預測期內（2024-2031年）將以複合年成長率為4.63%。

由於輸血需求的增加和對相容血液製品的需求，全球免疫血液學市場正在經歷顯著成長。促成這一成長的關鍵因素包括輸血醫學的進步、需要輸血支持的慢性疾病盛行率的增加以及創傷和外科手術頻率的增加。創新技術和自動化解決方案正在提高血型和相容性測試的效率和準確性。此外，向分子分析技術的轉變提高了準確性和可靠性。然而，先進設備和試劑的高成本、缺乏熟練的專業人員以及嚴格的監管要求等挑戰可能會阻礙進展。總體而言，由於對安全和相容的血液製品的需求在醫療保健領域仍然很重要，因此市場處於持續成長的有利位置。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

Grifols
QuidelOrtho
Immucor
Bio-Rad Laboratories
Beckman Coulter
Novartis
Quotient Limited
Diagast
Becton, Dickinson and Company
Thermo Fisher Scientific
Abbott Laboratories
BioMerieux
Hologic, Inc.
Werfen SA
Merck KGaA
DiaSorin SpA
F. Hoffmann-La Roche AG
Immucor Gamma Biologics
Tulip Diagnostics Pvt. Ltd.
Versiti

簡介目錄

Product Code: SQMIG35G2186

Global Immunohematology Market size was valued at USD 1.83 billion in 2022 and is poised to grow from USD 1.92 billion in 2023 to USD 2.76 billion by 2031, growing at a CAGR of 4.63% during the forecast period (2024-2031).

The global immunohematology market is experiencing significant growth, driven by the rising demand for blood transfusions and the need for compatible blood products. Key factors contributing to this growth include advancements in transfusion medicine, an increasing prevalence of chronic diseases that necessitate transfusion support, and a higher frequency of trauma and surgical procedures. Innovative technologies and automation solutions are enhancing the efficiency and accuracy of blood typing and compatibility testing. Additionally, the shift toward molecular immunohematology techniques is improving precision and reliability. However, challenges such as the high costs of advanced equipment and reagents, a shortage of skilled professionals, and stringent regulatory requirements may hinder progress. Overall, the market is well-positioned for continued growth, as the demand for safe and compatible blood products remains critical in healthcare settings.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Immunohematology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Immunohematology Market Segmental Analysis

Global Immunohematology Market is segmented by Product, End Use, and region. Based on Product , the market is segmented into Immunohematology analyzer, Immunohematology reagent. Based on End Use, the market is segmented into Hospitals, Blood banks, Diagnostic laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Drivers of the Global Immunohematology Market

One key driver of the global immunohematology market is the escalating demand for blood transfusion services. As the prevalence of chronic diseases, surgical interventions, and trauma cases rises, the need for safe and compatible blood products for transfusions becomes increasingly critical. Immunohematology is essential for ensuring that blood products match the recipient's blood type, thereby minimizing the risk of adverse reactions and enhancing patient outcomes. This necessity fuels the adoption of immunohematology testing and associated products in healthcare facilities.

Restraints in the Global Immunohematology Market

A significant constraint in the global immunohematology market is the high cost associated with testing and equipment. The advanced technologies and specialized reagents required for immunohematology testing can be quite expensive, posing challenges for healthcare facilities, especially in developing regions, to acquire these resources. Additionally, the necessity for skilled personnel to conduct and interpret immunohematology tests further contributes to the overall expenses. These financial limitations can restrict the accessibility and affordability of immunohematology services, particularly in resource-limited settings, ultimately hindering market growth and adoption.

Market Trends of the Global Immunohematology Market

A significant trend in the global immunohematology market is the growing adoption of automated and integrated systems for blood typing and cross-matching. Technological advancements have spurred demand for efficient and precise immunohematology testing methods. These automated systems provide advantages such as minimized human error, enhanced workflow efficiency, and quicker turnaround times for test results. They consolidate various processes, including sample preparation, antibody identification, and data analysis, into a unified platform, thereby boosting laboratory productivity. Additionally, integrating immunohematology systems with laboratory information management systems (LIMS) facilitates seamless data management and better traceability. This move towards automation and integration is motivated by the need for improved patient safety, increased operational efficiency, and enhanced laboratory performance.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Technology Analysis
Regulatory Landscape
Patent Analysis
PESTEL Analysis
Case Study Analysis

Immunohematology Market, By Product

Market Overview
Immunohematology analyzer
Immunohematology reagent

Immunohematology Market, By End Use

Market Overview
Hospitals
Blood banks
Diagnostic laboratories

Immunohematology Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Grifols
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QuidelOrtho
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Immucor
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beckman Coulter
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quotient Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Diagast
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioMerieux
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Werfen S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DiaSorin S.p.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Immucor Gamma Biologics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tulip Diagnostics Pvt. Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Versiti
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments